课题基金 / 基金详情

Mahanine: Chemical Inspiration for Leukemia Treatment

Mahanine: Chemical Inspiration for Leukemia Treatment
Mahanine:白血病治疗的化学灵感
批准号:
8412232
负责人:
MATTHEW Paul BRICHACEK
金额:
$5.22万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-16 至 2013-08-15

项目摘要

项目成果

MATTHEW Paul BRICHACEK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Since the 1940s, over half of the anticancer drugs developed are natural products or inspired by natural products. Anticancer drugs have traditionally been developed from compounds with broad potency against multiple cancer cell lines, but molecules that are selective for a particular type of cancer offer considerable promise. These selective compounds will enable a personalized cancer treatment that could reduce or eliminate the side effects associated with current generation cancer treatments. Mahanine is a naturally occurring compound that has demonstrated highly selective activity against leukemia cell lines. This proposal describes the synthesis of mahanine and novel analogues utilizing a 1) N-arylation and oxidative biaryl coupling and 2) Crombie chromene synthesis. With an efficient, scalable, and flexible route to mahanine, a small library of analogues will be synthesized to construct a detailed structure activity relationship. This information will facilitate the discovery of compounds with improved activity and selectivity. These more active analogues will provide a candidate for potential therapeutic use. In addition, detailed mechanistic studies will be performed in leukemia cells to precisely determine the mode of action and cellular target. Overall, this research will advance the study of leukemia and treatments for this deadly disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transformative Methods for the Solid Phase Synthesis of Oligosaccharides
  • 批准号:
    9751331
  • 项目类别:
  • 资助金额:
    $27.44万
  • 财政年份:
    2016
  • 负责人:
    MATTHEW Paul BRICHACEK
  • 依托单位:
Mahanine: Chemical Inspiration for Leukemia Treatment
海外基金